| Phase 2 | 1 |
| NCT ID | Title | Condition | Status | Updated |
|---|---|---|---|---|
| Phase 2 | ||||
| NCT02912949 | A Study of Zenocutuzumab (MCLA-128) in Patients With Solid Tumors Harboring an NRG1… | Solid Tumours Harboring NRG1 Fusion | Active, Not Recruiting | 2025-04-29 |
Lung Cancer (1) · Non-Small Cell Lung Cancer (NSCLC) (1) · Pancreatic Cancer (1)